 13. Has not recovered from the adverse effects of previous anti-cancer treatments to pre-treatment baseline or Grade 1, except for alopecia, anemia hemoglobin must meet the present study inclusion criterion, and peripheral neuropathy which must have recovered to Grade 2. 